Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GERN | IMMX |
|---|---|---|
| Price | $1.20 | $9.49 |
| Change today | ▼ 0.83% | ▼ 1.56% |
| Market cap | $770.97M | $788.42M |
| Return, 3 months | -23.1% | -14.4% |
| Return, year to date | -9.1% | +81.5% |
| Return, 1 year | -13.0% | +273.6% |
| P/E (TTM) | -10.9 | -10.8 |
| P/B | 3.5 | 3.4 |
| P/E percentile vs own 5y | 30th | 13th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +17.2% | – |
| Net profit growth (YoY) | -1.9% | -74.5% |
| Gross margin | 93.5% | – |
| Operating margin | -17.2% | – |
| Net margin | -33.1% | – |
| Return on equity | -28.3% | -34.2% |
| Analyst target vs. price | +191.7% | +170.5% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 33 | 33 |
| 30-day volatility | 44.6% | 58.8% |
| Max drawdown, 1 year | -43.6% | -39.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
